Market Value12,220,691,000
Total Holdings119
File Date2017-05-15
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
HRTX / Heron Therapeutics, Inc.
NLTX / Neoleukin Therapeutics, Inc.
CRBP / Corbus Pharmaceuticals Holdings, Inc.
US62857M1053 / MyoKardia, Inc.
ABEO / Abeona Therapeutics Inc.
US0153511094 / Alexion Pharmaceuticals, Inc.
AERI / Aerie Pharmaceuticals Inc
FOMX / Foamix Pharmaceuticals Ltd.
SELB / Selecta Biosciences Inc
NERV / Minerva Neurosciences, Inc.
MGNX / MacroGenics, Inc.
CYCCP / Cyclacel Pharmaceuticals, Inc. - Preferred Stock
ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock)
AGLE / Aeglea BioTherapeutics Inc
SGEN / Seagen Inc
IDRA / Idera Pharmaceuticals, Inc.
HALO / Halozyme Therapeutics, Inc.
ONC / BeOne Medicines AG - Depositary Receipt (Common Stock)
MDGN / Medgenics, Inc.
CFRX / ContraFect Corp
TNXP / Tonix Pharmaceuticals Holding Corp.
CPRX / Catalyst Pharmaceuticals, Inc.
TRIL / Trillium Therapeutics Inc
SGMO / Sangamo Therapeutics, Inc.
NTLA / Intellia Therapeutics, Inc.
MDGL / Madrigal Pharmaceuticals, Inc.
INSM / Insmed Incorporated
INCY / Incyte Corporation
451731103 / Ignyta, Inc.
AVXS / AveXis, Inc.
FSTX / F-star Therapeutics Inc
BDSI / Biodelivery Sciences International
FMI / Foundation Medicine, Inc.
BTX.WS / BioTime, Inc. Warrants exp. 2018-10-01
ABBV / AbbVie Inc.
SCYX / SCYNEXIS, Inc.
PTN / Palatin Technologies, Inc.
JUNO / Juno Therapeutics, Inc.
OSIR / Osiris Therapeutics, Inc.
BIIB / Biogen Inc.
74365AAB7 / Protalix BioTherapeutics, Inc. Bonds 4.5% 9/15/18
STML / Stemline Therapeutics, Inc.
09061GAD3 / BioMarin Pharmaceutical Inc. Bond 1.875% 4/23/2017
US670002AB05 / Novavax, Inc. Bond 3.75% Due 2/1/2023
EXEL / Exelixis, Inc.
GLYC / GlycoMimetics, Inc.
APTO / Aptose Biosciences Inc.
DERM / Journey Medical Corporation
TMBR / Timber Pharmaceuticals Inc
ALDR / Alder BioPharmaceuticals, Inc.
04269XAA3 / Array BioPharma Inc. Bonds 3.0% 6/1/2020
AAAP / Advanced Accelerator Applications S.A
DMTX / Dimension Therapeutics, Inc.
US00767EAB83 / Aegerion Pharmaceuticals, Inc. 2.0% Bond due 2019-08-15
ONCE / Spark Therapeutics, Inc.
MDWD / MediWound Ltd.
NDRM / NeuroDerm Ltd.
45780VAB8 / Inotek Pharmaceuticals Corporation Bonds 5.75% 8/1/2021
IMDZ / Immune Design Corp.
LGND / Ligand Pharmaceuticals Incorporated
CNCE / Concert Pharmaceuticals Inc
PRQR / ProQR Therapeutics N.V.
CLCD / CoLucid Pharmaceuticals, Inc.
US00448Q2012 / Achillion Pharmaceuticals, Inc.
GHDX / Genomic Health, Inc.
BIVV / Bioverativ Inc.
QURE / uniQure N.V.
ADMS / Adamas Pharmaceuticals Inc
ALNY / Alnylam Pharmaceuticals, Inc.
JNCE / Jounce Therapeutics Inc
ASMB / Assembly Biosciences, Inc.
PGNX / Progenics Pharmaceuticals, Inc.
NVIV / InVivo Therapeutics Holdings Corp.
NBRV / Nabriva Therapeutics Plc
CLLS / Cellectis S.A. - Depositary Receipt (Common Stock)
ZGNX / Zogenix Inc
WINT / Windtree Therapeutics, Inc.
US33830X1046 / Five Prime Therapeutics Inc
ARCT / Arcturus Therapeutics Holdings Inc.
ABUS / Arbutus Biopharma Corporation
EPZM / Epizyme Inc
RIGL / Rigel Pharmaceuticals, Inc.
0HBB / Aimmune Therapeutics Inc
ARAV / Aravive, Inc.
BCRX / BioCryst Pharmaceuticals, Inc.
IONS / Ionis Pharmaceuticals, Inc.
09061GAE1 / BioMarin Pharmaceutical Inc. Bond 0.75% 10/15/2018
MCRB / Seres Therapeutics, Inc.
/ Achaogen Inc
ITCI / Intra-Cellular Therapies, Inc.
GLPG / Galapagos NV - Depositary Receipt (Common Stock)
CMRX / Chimerix, Inc.
INFI / Infinity Pharmaceuticals Inc.
RARX / Ra Pharmaceuticals, Inc.
LOXO / Loxo Oncology, Inc.
US00484MAA45 / Acorda Therapeutics, Inc. Bond 1.750% 6/1
/ Array BioPharma, Inc.
AKTX / Akari Therapeutics, Plc - Depositary Receipt (Common Stock)
SYRS / Syros Pharmaceuticals, Inc.
ANAB / AnaptysBio, Inc.
BMRN / BioMarin Pharmaceutical Inc.
KPTI / Karyopharm Therapeutics Inc.
FLGT / Fulgent Genetics, Inc.
ALDX / Aldeyra Therapeutics, Inc.
LJPC / La Jolla Pharmaceutical Co.
QLGN / Qualigen Therapeutics, Inc.
SRRA / Sierra Oncology Inc
DSCI / Derma Sciences, Inc.
ACOR / Acorda Therapeutics, Inc.
AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock)
CCXI / ChemoCentryx Inc
TENX / Tenax Therapeutics, Inc.
XNCR / Xencor, Inc.
TARA / Protara Therapeutics, Inc.
SAGE / Sage Therapeutics, Inc.
ENTA / Enanta Pharmaceuticals, Inc.
TRVN / Trevena, Inc.
VIRX / Viracta Therapeutics, Inc.
NBIX / Neurocrine Biosciences, Inc.
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
BLCM / Bellicum Pharmaceuticals, Inc.
DVAX / Dynavax Technologies Corporation
RARE / Ultragenyx Pharmaceutical Inc.
XLRN / Acceleron Pharma Inc
AGIO / Agios Pharmaceuticals, Inc.
CBAY / CymaBay Therapeutics, Inc.
CERS / Cerus Corporation
IMGN / ImmunoGen, Inc.
AFMD / Affimed N.V.
NTRA / Natera, Inc.
BLUE / bluebird bio, Inc.
MRUS / Merus N.V.
ALKS / Alkermes plc
NVTA / Invitae Corporation
MRTX / Mirati Therapeutics, Inc.
DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock)
ACAD / ACADIA Pharmaceuticals Inc.